Shopping Cart
- Remove All
Your shopping cart is currently empty
CAY10770 is an inhibitor of the cytochrome P450 (CYP) isoform CYP4Z1 (IC50= 5.9 μM).1It is selective for CYP4Z1 over CYP4A11, CYP4F2, CYP4F3a, CYP4F3b (IC50s = 187-282 μM) but does inhibit CYP4F8 and CYP4F12 (IC50s = 167 and 91 μM, respectively). CAY10770 (3 μM) inhibits the production of 14(15)-EET, 19-HETE, and 14(15)-DiHET by 83, 86, and 80%, respectively, in T47D breast cancer cells expressing CYP4Z1.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 250 μg | $223 | 35 days | |
| 500 μg | $417 | 35 days | |
| 1 mg | $783 | 35 days |
| Description | CAY10770 is an inhibitor of the cytochrome P450 (CYP) isoform CYP4Z1 (IC50= 5.9 μM).1It is selective for CYP4Z1 over CYP4A11, CYP4F2, CYP4F3a, CYP4F3b (IC50s = 187-282 μM) but does inhibit CYP4F8 and CYP4F12 (IC50s = 167 and 91 μM, respectively). CAY10770 (3 μM) inhibits the production of 14(15)-EET, 19-HETE, and 14(15)-DiHET by 83, 86, and 80%, respectively, in T47D breast cancer cells expressing CYP4Z1. |
| Synonyms | CAY10770 |
| Molecular Weight | 276.33 |
| Formula | C14H20N4O2 |
| Cas No. | 2428734-45-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Chloroform: 10 mg/mL (36.19 mM), Sonication is recommended. Methyl Acetate: 1 mg/mL (3.62 mM), Sonication is recommended. Ethanol: 1 mg/mL (3.62 mM), Sonication is recommended. |
Solution Preparation Table | |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.